How Age Affects Fertility and IVF Success — What Every Woman Should Know

Age is one of the most honest conversations in reproductive medicine. Unlike many fertility factors that can be treated or reversed, the biological relationship between age and fertility follows a predictable, well-understood curve. Understanding where you are on that curve and what it means for your options is one of the most empowering things you can do as you plan for pregnancy.

At the best fertility centre in Hebbal, Dr. Aravind's IVF Fertility & Pregnancy Centre, age-sensitive care means every diagnostic and treatment decision is made with your specific reproductive timeline in mind, not a generic protocol.

Why Age Matters More Than Most People Realise

Women are born with a fixed number of eggs, approximately 1–2 million at birth, declining to around 300,000 by puberty, and continuing to fall throughout reproductive life. By the mid-30s, both the quantity and quality of remaining eggs declined noticeably. By 40, the rate of chromosomally abnormal eggs rises sharply which is why miscarriage rates increase and IVF success rates fall with advancing age.

This is not cause for alarm. It is biology and understanding it clearly helps couples make better, faster, more confident decisions.

Fertility by Age Bracket — A Practical Overview

Ages 30–34 This is still a strong fertility window for most women. Natural conception remains highly likely for those without underlying conditions. However, this is also the ideal time for a baseline fertility assessment AMH testing, antral follicle count, and hormonal panel so that any early signs of diminished ovarian reserve are caught before they narrow treatment options.

Ages 35–39 Thirty-five is the clinical inflection point. Egg quality declines more noticeably, chromosomal error rates in embryos begin to rise, and the monthly probability of natural conception drops. Women in this bracket who have been trying for 6 months without success should seek specialist evaluation without delay. IVF success rates remain meaningful in this group particularly with blastocyst culture and PGT-A embryo screening but time matters more than it did at 32.

Ages 40–44 Ovarian reserve is typically reduced significantly by this stage. IVF with its own eggs remains possible for many women, but the number of retrievable eggs per cycle decreases, and the proportion of chromosomally normal embryos falls. Donor egg IVF becomes a realistic, clinically appropriate conversation not a failure, but a pathway to parenthood that many women find deeply fulfilling.

Ages 45 and Above Natural conception with its own eggs is rare. The vast majority of successful pregnancies at this age involve donor eggs. Uterine function often remains good, which means the ability to carry a pregnancy with appropriate hormonal support is frequently preserved well into the mid-40s.

Key Tests Every Woman Over 30 Should Know About

AMH (Anti-Müllerian Hormone) — The most reliable marker of ovarian reserve. A low AMH does not prevent pregnancy but indicates fewer eggs remaining and guides stimulation planning.

Antral Follicle Count (AFC) — An ultrasound count of resting follicles visible in both ovaries. Directly predicts egg yield in an IVF cycle.

FSH and Estradiol — Measured on Day 2–3 of the cycle. Elevated FSH signals reduced ovarian reserve. Estradiol is measured alongside FSH to interpret the result accurately.

Uterine Assessment — A saline infusion sonogram or hysteroscopy identifies polyps, fibroids, or cavity abnormalities that could impair implantation — regardless of age.

According to the American Society for Reproductive Medicine, women over 35 who have been trying to conceive for 6 months without success should seek a fertility evaluation promptly; earlier intervention consistently improves cumulative outcomes.

PGT-A — Why Embryo Screening Matters More After 35

Preimplantation Genetic Testing for Aneuploidies (PGT-A) screens embryos for chromosomal abnormalities before transfer. For women over 35, this test significantly reduces miscarriage risk and improves the probability of a successful live birth per transfer because it ensures only chromosomally normal embryos are selected.

Your Next Step — By Age

30–34: Get a baseline assessment. Knowledge now protects options later. 35–39: Move efficiently. Investigate thoroughly. Consider IVF sooner rather than later. 40+: Prioritise speed. Discuss donor options openly. Focus on embryo quality over quantity.

Whatever your age, the path forward is clearer than it feels right now. Book your age-specific fertility consultation at Dr. Aravind's IVF Fertility & Pregnancy Centre and let clinical expertise, honest guidance, and genuine compassion map your personalised route to parenthood.

FAQ

Q1. What AMH level is considered low for a woman in her 30s? An AMH below 1.0 ng/mL is generally considered low for a woman in her early-to-mid 30s. Below 0.5 ng/mL indicates significantly diminished reserve. However, AMH alone does not determine treatment options; it is one part of a complete diagnostic picture.

Q2. Is PGT-A recommended for all women over 35? PGT-A is strongly recommended for women over 37, those with recurrent implantation failure, and those with a history of miscarriage. For women aged 35–37 with good embryo yield, it is discussed case-by-case based on individual clinical profile.

Q3. What is the difference between ovarian reserve and egg quality? Ovarian reserve refers to the quantity of eggs remaining. Egg quality refers to chromosomal and metabolic integrity of individual eggs. A woman can have a good reserve with poor quality eggs (common in older patients) or low reserve with good quality eggs (common in young women with early menopause). Both matter and both are assessed separately.

Q4. Does Dr. Aravind's IVF Fertility & Pregnancy Centre offer donor egg IVF for women over 40? Yes. Donor egg IVF is offered as part of a comprehensive range of fertility pathways with full counselling, legal guidance, and matching support for couples who choose this route.